MegaNatural-BP claims supported
This article was originally published in The Tan Sheet
Executive Summary
Constellation Wines U.S./PolyPhenolics supports certain claims for its MegaNatural-BP dietary supplement, but should "clearly and conspicuously" communicate the supplement could be used as a part of a lifestyle management program by those with prehypertension and metabolic syndrome, the National Advertising Division states in an Oct. 14 decision. The advertiser submitted two clinical trials, which NAD says provide a reasonable basis for claims such as: "In the second study on participants with prehypertension, their systolic blood pressure dropped 8 mm and diastolic dropped 5 mm when taking 300 mg once per day for 2 months." The Council for Better Business Bureaus group recommends discontinuing the claim, "Provide relief with half the cost, half the dose and half the time," but says the advertiser can discuss the differences between MegaNatural-BP and antigen-converting enzyme inhibitors